Series 5: episode 2
Tune in to the next episode of the GOLD podcast to hear the team’s latest conversation with a leading figure in the pharmaceutical industry. What is being discussed this week? The industry’s evolving commercial model.
In this week’s episode, Isabel chats with Chetak Buaria, Vice President of Global Commercial Operations, Oncology, Merck Group, about how a new model driven by technology and data is in sight. The two explore what this new model might look like, whether pharma is ready for it and how to move forward without alienating internal or external stakeholders.
The opinions and views expressed here are his personal and do not necessarily reflect the opinions or views of Merck Healthcare KGaA, Germany or any subsidiary thereof.
A little more on GOLD’s guest…
Chetak Buaria, Vice President of Global Commercial Operations, Oncology, joined the Merck Group in 2007, starting in Mumbai as Head of Mergers and Acquistions, Licensing and Strategic Marketing. Now based in Germany, he works to drive growth and performance across Merck’s portfolio of brands in oncology. Always looking for new challenges, he has a Masters of Pharmaceutical Sciences, an MBA and a passion for innovation.
